OakChart

Elanco Animal Health Inc

ELANHealthcare·Drug Manufacturers - Specialty & Generic·USA·Large·NYSE·Nov 11 • 11:02 AM ET

26.40-0.36 (-1.35%)
2026-11-11 17:03 CET
Market cap
13,375.37 USD m
Revenue, TTM
5,148.00 USD m
Net income, TTM
-147.00 USD m
Free cash flow, TTM
408.00 USD m
EPS diluted, TTM
-0.30
P/E
-
Compare

Price

ELAN against its 20, 50 and 200-day averages
2050200beat
20.0022.0024.0026.0028.0011.2M22.5MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ELANclose 26.4020-day 23.9550-day 23.29200-day 23.8326.4052w high52w low

5.6% under the 52-week high of 27.98 on 5 Aug 2026. 52-week low 19.40 on 19 May 2026. Last 15 sessions, 23.0% high to low

Profile

ELAN
52-week range, 82% of the way up
19.4027.98

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. The company was founded in 1954 and is headquartered in Indianapolis, IN.

IndexRUI
Employees9900
IPOSep 20, 2018
Beta1.69
ATR, 14d0.94
Rel volume0.37
Short float6.66%
Insider own1.02%
Inst own114.51%

Snapshot

6 groups

Valuation

IndexRUI
Market Cap13.20B
Enterprise Value16.44B
Income-147.00M
Sales5.15B
Book/sh13.26
Cash/sh0.93
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees9900
IPOSep 20, 2018

Ratios

P/E-
Forward P/E20.35
PEG1.30
P/S2.56
P/B1.99
P/C28.38
P/FCF32.34
EV/EBITDA15.16
EV/Sales3.19
Quick Ratio1.07
Current Ratio2.09
Debt/Eq0.56
LT Debt/Eq0.55
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.30
EPS next Y1.30
EPS next Q0.18
EPS this Y24.90%
EPS next Y10.47%
EPS next 5Y15.65%
EPS past 3/5Y-43.04% 18.11%
Sales past 3/5Y2.25% 7.57%
EPS Y/Y TTM-507.13%
Sales Y/Y TTM12.13%
EPS Q/Q151.90%
Sales Q/Q11.26%
EarningsNov 06 BMO
EPS/Sales Surpr.33.14% 4.69%

Ownership

Insider Own1.02%
Insider Trans1.37%
Inst Own114.51%
Inst Trans4.23%
ROA-1.09%
ROE-2.20%
ROIC-1.43%
Gross Margin45.30%
Oper. Margin7.58%
Profit Margin-2.86%
SMA2010.23%
SMA5013.34%
SMA20010.78%
Trades-

Technical

Shs Outstand499.73M
Shs Float494.72M
Short Float6.66%
Short Ratio6.02
Short Interest32.92M
52W High27.98 -5.65%
52W Low19.40 36.08%
Volatility5.75% 3.70%
ATR (14)0.94
RSI (14)65.73
Beta1.69
Rel Volume0.37
Avg Volume5.47M
Volume561,891

Performance

Perf Week4.31%
Perf Month17.80%
Perf Quarter17.28%
Perf Half Y21.10%
Perf YTD16.66%
Perf Year15.49%
Perf 3Y147.19%
Perf 5Y-19.37%
Perf 10Y-
Recom1.41
Target Price31.25
Prev Close26.76
Price26.40
Change %-1.35%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 20, 2026DowngradeJJefferiesBuy → Hold$24-9.1%
Oct 16, 2026InitiatedGGoldmanBuy$32+21.2%
Apr 15, 2026InitiatedCCitigroupBuy$30+13.6%
Jan 22, 2026UpgradePPiper SandlerNeutral → Overweight
Dec 09, 2025InitiatedBBarclaysOverweight$30+13.6%
Nov 21, 2025InitiatedKKeyBanc Capital MarketsOverweight$27+2.3%
Nov 19, 2025UpgradeAArgusHold → Buy$25-5.3%
Oct 07, 2025UpgradeJJP MorganNeutral → Overweight$24-9.1%
Jul 17, 2025UpgradeLLeerink PartnersMarket Perform → Outperform$18-31.8%
Jun 26, 2025UpgradeWWilliam BlairMkt Perform → Outperform

Peers

Mkt cap
TickerCompanyMkt cap
ZTSZoetis Inc32.94B
PAHCPhibro Animal Health Corp1.41B
IDXXIdexx Laboratories Inc55.02B
MRKMerck & Co Inc358.62B
NEOGNeogen Corp2.56B
CHWYChewy Inc9.08B
CENTCentral Garden & Pet Co2.61B
TRUPTrupanion Inc1.47B
FRPTFreshpet Inc3.00B
WOOFPetco Health and Wellness Co Inc832.05M

Insider trading

13 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Bettington Timothy JSEE REMARKSOct 15 '26Sale23.004,350100,050138,911Oct 19 04:15 PM
Bettington Timothy JOfficerOct 15 '26Proposed Sale23.004,350100,050Oct 15 04:01 PM
Kurzius Lawrence ErikDirectorAug 20 '26Buy23.4040,000935,920188,647Aug 21 04:16 PM
O'Neill ShivGC AND CORP SECAug 18 '26Buy23.583,99894,27387,832Aug 18 04:32 PM
Harrington Michael JDirectorAug 12 '26Buy21.825,000109,100131,451Aug 13 04:28 PM
VanHimbergen Robert MEVP and CFOAug 07 '26Buy23.084,20096,926137,516Aug 10 04:14 PM
Herendeen PaulDirectorAug 07 '26Buy23.6810,000236,850111,687Aug 10 04:13 PM
Modi Rajeev A.SEE REMARKSMay 15 '26Buy20.354,91199,939160,812May 19 04:39 PM
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORMay 15 '26Buy20.094,97199,843171,971May 19 04:38 PM
Kurzius Lawrence ErikDirectorDec 12 '25Buy21.3010,000213,000131,773Dec 16 04:42 PM
Modi Rajeev A.SEE REMARKSDec 11 '25Buy21.334,50095,985123,082Dec 15 04:43 PM
VanHimbergen Robert MEVP and CFODec 11 '25Buy21.646,950150,426124,233Dec 15 04:42 PM
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORDec 11 '25Buy21.7522,000478,496167,000Dec 15 04:41 PM

Held by

AUM
TickerCompanyAUM
IJHiShares Core S&P Mid-Cap ETFAUM: 124.48B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
DFSVUS Small Cap Value Portfolio ETF Class Shares-
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
DFATU.S. Targeted Value Portfolio-ETF Class Shares-
VXFVanguard Extended Market Index ETFAUM: 30.47B
MDYState Street SPDR S&P MIDCAP 400 ETF TrustAUM: 26.22B
XMMOInvesco S&P MidCap Momentum ETFAUM: 6.37B
DFASU.S. Small Cap Portfolio-ETF Class Shares-

News

latest 14 of 206
  • Elanco Beats And Raises For A Fourth Straight Time, But A Slower Q4 And 2027 Comparisons Temper The Margin Story (Earnings Whispers) +8.70%
  • Elanco Animal Health Shares Jump 7.6% as Q3 Earnings Beat Forecasts and Company Raises 2026 Outlook (InvestorsHub)
  • October Consumer Research Confirms Pet Health Remains Non-Negotiable Household Priority (PR Newswire)
  • Elanco Animal Health Reports Third Quarter 2026 Results (PR Newswire)
  • Moderna earnings due after spectacular rally (MarketWatch)
  • Loading…
  • Stock Market Today: Dow, S&P 500 and Nasdaq set for mixed start after AI carnage led to worst day for techs since 2020; jobs report on tap: live updates (MarketWatch)
  • Elanco to Participate in UBS Global Healthcare Conference (PR Newswire)
  • Elanco's Fourth Straight Raise Meets A Skeptical Market As Zenrelia Momentum Faces Test (Earnings Whispers)
  • Caring for Both Ends of the Leash: Elanco and The Veterinary Cooperative Support The Street Dog Coalition (ACCESSWIRE)
  • Addressing Critical Health Needs Through Innovation (ACCESSWIRE)
  • Elanco Animal Health Appoints Jamie Preston as Chief People Officer (PR Newswire)
  • Jefferies downgrades Zoetis, Elanco on pricing risk; prefers IDEXX (Investing.com)
  • Transparency, Connection, The Future of Care with Dr. Molly Brinkmann, @DrMollySays (ACCESSWIRE)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-060.2700.2030.0401,2651,20813
2026Q22026-08-050.3400.2690.1071,3681,31214
2026Q12026-05-060.4000.3460.1131,3711,27714
2025Q42026-02-240.1300.114-0.5551,1441,09315
2025Q32025-11-050.1900.130-0.0681,1371,09212
2025Q22025-08-070.2600.1990.0221,2411,18613
2025Q12025-05-070.3700.3060.1351,1931,16912
2024Q42025-02-250.1400.149-0.0161,0201,00913
2024Q32024-11-070.1300.1220.7311,0301,03612
2024Q22024-08-080.3000.240-0.1011,1841,14812
2024Q12024-05-080.3400.2740.0651,2051,18813
2023Q42024-02-260.0800.105-0.2861,0351,00211
2023Q32023-11-070.1800.125-2.2251,0681,0407
2023Q22023-08-070.1800.047-0.1971,0571,03810
2023Q12023-05-090.4500.2850.2091,2571,19310
2022Q42023-02-210.1900.127-0.111988980.9411

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY1.0601.0590.1833,0713,074
2020FY0.4700.452-1.2693,2733,189
2021FY1.0401.007-0.9914,7654,755
2022FY1.1101.043-0.1604,4184,410
2023FY0.8900.920-2.5014,4174,385
2024FY0.9100.9130.6804,4394,422
2025FY0.9400.933-0.4704,7154,663
2026FY-1.174--5,185
2027FY-1.297--5,449
2028FY-1.454--5,714
2029FY-1.560--5,913
2030FY-1.705--6,150

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0911421,1991,1801,216
2026Q4S2026-11-0611321,1981,1801,216
2026Q4S2026-11-0411001,1931,1651,233
2026Q4S2026-10-2411011,1931,1651,233
2026Q4S2026-10-2311021,1931,1651,233
2026Q4S2026-10-2011021,1921,1651,233
2026Q4S2026-10-1911031,1921,1651,233
2026Q4S2026-10-1611261,1921,1651,233
2026Q4S2026-10-1512261,1911,1651,233
2026Q4S2026-10-0911261,1871,1651,211
2026Q4S2026-09-2511261,1871,1651,211
2026Q4S2026-09-0712261,1861,1651,211
2026Q4S2026-08-2112361,1861,1651,211
2026Q4S2026-08-1012351,1881,1651,211

Estimate history

EPS, annual-0.850.2760.183-1.269-0.991-0.16-2.5010.68-0.467-0.3005
Period201720182019202020212022202320242025TTM
EPS, quarterly0.731-0.0160.1350.022-0.068-0.5550.1130.1070.036
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual28893066.830713273.3476444114417443947155148
Period201720182019202020212022202320242025TTM
Sales, quarterly103010201193124111371144137113681265
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual365.625365.644373.012471.921473.12474.238492.845494.446496.975499.727
Period201720182019202020212022202320242025MRQ
Shares, quarterly494.333494.446496.458496.646496.83496.975499.382499.55499.727
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue5,148.004,715.004,439.004,417.004,411.004,764.003,273.303,071.003,066.80
Cost of Goods Sold Incl. D&A2,816.002,665.002,530.002,479.002,441.002,688.002,026.501,670.701,771.20
Gross Profit2,332.002,050.001,909.001,938.001,970.002,076.001,246.801,400.301,295.60
Selling, General and Administrative Excl. Other1,942.001,798.001,658.001,612.001,586.001,772.001,323.601,030.30981.80
Research and Development381.00368.00344.00327.00321.00369.00327.00270.10246.60
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income390.00252.00251.00326.00384.00304.00-76.80370.00313.80
Interest Expense298.00300.00339.00277.00256.00264.00156.0078.9029.60
Unusual Expense183.00203.00172.001,162.00188.00680.00625.30193.00167.20
Net Income Before Taxes-92.00-224.00488.00-1,195.00-72.00-571.00-672.0078.20114.10
Income Taxes55.008.00150.0036.006.00-88.00-111.9010.3027.60
Consolidated Net Income-147.00-232.00338.00-1,231.00-78.00-483.00-560.1067.9086.50
Net Income From Continuing Operations-147.00-232.00338.00-1,231.00-78.00-483.00-560.1067.9086.50
Net Income-147.00-232.00338.00-1,231.00-78.00-483.00-560.1067.9086.50
EPS (Recurring)-0.04-0.180.92-0.850.11-0.01-0.280.550.65
EPS (Basic, Before Extraordinaries)-0.30-0.470.68-2.50-0.16-0.99-1.270.180.28
EPS (Diluted)-0.30-0.470.68-2.50-0.16-0.99-1.270.180.28
EBITDA1,084.00932.00913.001,020.001,066.001,020.00440.10684.50609.80
Non-Operating Income (Expense)-1.0027.00748.00-82.00-12.0069.00186.10-19.90-2.90
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-53.7243.4536.3454.0055.0042.3030.9020.54
Price To Earnings Ratio--29.64----159.02133.26
Price To Sales Ratio2.202.381.361.661.352.904.143.553.23
Gross Margin45.3043.4843.0143.8844.6643.5838.0945.6042.25
Operating Margin7.585.345.657.388.716.38-2.3512.0510.23
Net Margin-2.86-4.927.61-27.87-1.77-10.14-17.112.212.82
Shares Outstanding499.73496.98494.45492.85474.24473.12471.92373.01365.64
Market Capitalization13,375.3713,375.375,986.617,342.695,794.7913,424.2814,473.6310,984.9711,528.16

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue1,265.001,368.001,371.001,144.001,137.001,241.001,193.001,020.00
Cost of Goods Sold Incl. D&A689.00709.00724.00694.00670.00664.00637.00631.00
Gross Profit576.00659.00647.00450.00467.00577.00556.00389.00
Selling, General and Administrative Excl. Other492.00541.00478.00431.00440.00492.00435.00381.00
Research and Development99.0092.0097.0093.0089.0092.0094.0081.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income84.00118.00169.0019.0027.0085.00121.008.00
Interest Expense68.0066.0073.0091.0075.0070.0053.0062.00
Unusual Expense-20.00-8.0017.00194.0023.00-8.0024.0032.00
Net Income Before Taxes24.0056.0087.00-259.00-50.0025.0060.00-51.00
Income Taxes6.002.0030.0017.00-16.0014.00-7.00-43.00
Consolidated Net Income18.0054.0057.00-276.00-34.0011.0067.00-8.00
Net Income From Continuing Operations18.0054.0057.00-276.00-34.0011.0067.00-8.00
Net Income18.0054.0057.00-276.00-34.0011.0067.00-8.00
EPS (Recurring)0.010.100.14-0.28-0.040.010.170.03
EPS (Basic, Before Extraordinaries)0.040.110.11-0.56-0.070.020.14-0.02
EPS (Diluted)0.040.110.11-0.56-0.070.020.14-0.02
EBITDA261.00289.00341.00193.00203.00254.00282.00172.00
Non-Operating Income (Expense)-12.00-4.008.007.0021.002.0016.0035.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense15.80--9.4824.4911.8515.801.5822.12
Price To Earnings Ratio---310.4323.0819.0615.4829.64
Price To Sales Ratio2.202.482.472.382.181.591.181.35
Gross Margin45.5348.1747.1939.3441.0746.4946.6138.14
Operating Margin6.648.6312.331.662.376.8510.140.78
Net Margin1.423.954.16-24.13-2.990.895.62-0.78
Shares Outstanding499.73499.55499.38496.98496.83496.65496.46494.45
Market Capitalization13,375.3712,291.4611,897.2311,244.0110,005.837,092.105,193.455,986.61

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments545.00468.00352.00345.00638.00505.40345.10677.50323.40
Short Term Receivables1,053.001,007.001,159.001,002.001,028.001,076.70889.90709.40601.90
Inventories1,737.001,574.001,735.001,538.001,371.001,578.101,050.701,004.101,062.30
Other Current Assets123.00166.00161.00394.00237.00256.3087.40113.90136.10
Total Current Assets3,458.003,215.003,407.003,279.003,274.003,416.502,373.102,504.902,123.70
Net Property, Plant & Equipment1,525.001,115.001,166.001,140.001,216.001,503.401,040.30922.40920.30
Total Investments and Advances15.0017.0026.0037.0030.0035.7021.1015.3012.30
Intangible Assets8,187.008,095.009,588.0010,835.0011,759.0012,612.105,472.405,411.005,642.00
Other Assets173.00172.00175.00200.00199.00125.0078.90103.10242.00
Total Assets13,358.0012,614.0014,362.0015,491.0016,478.0017,692.708,985.808,956.708,940.30
Short Term Debt Incl. Current Port. of LT Debt112.0075.0070.00419.00328.00591.5048.2029.000.00
Accounts Payable368.00296.00270.00390.00416.00506.00239.00205.20203.80
Income Tax Payable--------4.80
Other Current Liabilities1,117.00944.00901.00893.00903.00978.80531.30736.50424.00
Total Current Liabilities1,597.001,315.001,241.001,702.001,647.002,076.30818.50970.70632.60
Long Term Debt4,029.004,369.005,846.005,559.006,152.005,723.802,392.202,443.300.00
Provision for Risks Charges158.00175.00184.00161.00271.00346.5087.20109.10139.00
Deferred Tax Liabilities382.00449.00567.00662.00765.00900.30100.80114.60251.90
Other Liabilities645.00210.00301.00118.00135.00169.9040.20121.50126.00
Total Liabilities6,811.006,518.008,139.008,202.008,970.009,216.803,438.903,759.201,149.50
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity6,547.006,096.006,223.007,289.007,508.008,475.905,546.905,197.507,790.80
Total Shareholders Equity6,547.006,096.006,223.007,289.007,508.008,475.905,546.905,197.507,790.80
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity6,547.006,096.006,223.007,289.007,508.008,475.905,546.905,197.507,790.80
Total Liabilities & Stockholders Equity13,358.0012,614.0014,362.0015,491.0016,478.0017,692.708,985.808,956.708,940.30
Book Value Per Share13.1712.3312.6315.3715.8717.9614.8714.2121.31
Tangible Book Value Per Share-3.30-4.04-6.83-7.48-8.99-8.760.20-0.585.88
Full-Time Employees9,9009,4509,8009,7409,8009,4005,7605,7806,075
Price to Book Ratio2.020.921.200.861.781.711.982.222.23
Return on Assets-1.792.51-8.25-0.49-2.83-4.200.760.97-3.48
Return on Equity-3.675.49-18.22-1.05-6.04-7.991.261.33-3.99
Return on Invested Capital-2.193.23-10.20-0.61-3.54-3.940.861.13-3.99
Quick Ratio1.081.251.351.021.160.891.621.551.68
Current Ratio2.172.442.751.931.991.652.902.583.36

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-147.00-232.00338.00-1,231.00-78.00-483.00-560.1067.9086.50
Depreciation694.00680.00662.00694.00682.00716.00516.90314.50296.00
Other Funds (Non Cash)246.00147.00-496.001,188.00367.00486.00-38.7069.30194.70
Funds from Operations659.00461.00392.00571.00914.00571.00-206.70451.80516.50
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-45.0099.00149.00-300.00-462.00-88.00165.70-227.70-29.20
Cash from Operating Activities614.00560.00541.00271.00452.00483.00-41.00224.10487.30
Capital Expenditures-206.00-276.00-161.00-154.00-184.00-197.00-310.90-197.40-134.50
Net Assets From Acquisitions-76.000.00-41.00-19.000.00-342.00-5,001.30-32.800.00
Sale of Fixed Assets and Businesses0.009.001,360.000.0013.0017.00507.400.309.40
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses-14.00-12.000.000.00-8.00-8.00-7.10-4.90-1.90
Other Sources0.000.000.004.00--32.70-0.00
Cash from Investing Activities-296.00-279.001,158.00-169.00-179.00-530.00-4,779.20-234.80-127.00
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.001,219.900.001,659.70
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.001,219.900.001,659.70
Proceedsfrom Stock Options0.000.000.000.000.000.001,219.900.001,659.70
Issuance or Reduction of Debt, Net-305.00-563.00-1,475.00-77.00-504.00175.003,750.20-121.102,468.00
Change in Long Term Debt-305.00-563.00-1,475.00-77.00-504.00175.003,750.20-121.102,468.00
Issuance of Long Term Debt2,156.002,356.00570.00600.00986.00998.004,701.700.002,475.50
Reduction of Long Term Debt-2,461.00-2,919.00-2,045.00-677.00-1,490.00-823.00-951.50-121.10-7.50
Net Financing Active Other Cash Flow-68.00288.00-17.00-6.00-45.0035.00-16.20-183.70-4,162.90
Other Financing Activities Uses-53.00-2.00-17.00-6.00-45.00-29.00-16.20-183.70-4,162.90
Cash from Financing Activities-373.00-275.00-1,492.00-83.00-549.00210.004,953.90-304.80-35.20
Exchange Rate Effect15.0071.00-91.00-12.00-17.00-31.0026.60-16.9029.00
Net Change in Cash-40.0077.00116.007.00-293.00132.00160.30-332.40354.10
Free Cash Flow408.00284.00394.00131.00315.00357.00-175.6083.70352.80
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow27.8039.5515.2955.9918.9438.73-130.2928.04
Deferred Taxes & Investment Tax Credit--134.00-112.00-80.00-57.00-148.00-124.800.10-60.70

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments465.00530.00428.00545.00505.00539.00
Short Term Receivables1,063.001,152.001,154.001,053.00975.001,103.00
Inventories1,818.001,769.001,717.001,737.001,708.001,670.00
Other Current Assets380.00346.00285.00123.00305.00302.00
Total Current Assets3,726.003,797.003,584.003,458.003,493.003,614.00
Net Property, Plant & Equipment1,438.001,411.001,395.001,525.001,392.001,357.00
Total Investments and Advances13.0013.0013.0015.0015.0014.00
Intangible Assets7,829.008,049.007,948.008,187.008,360.008,463.00
Other Assets334.00291.00282.00173.00291.00294.00
Total Assets13,340.0013,561.0013,222.0013,358.0013,551.0013,742.00
Short Term Debt Incl. Current Port. of LT Debt74.0073.0073.00112.0062.0061.00
Accounts Payable416.00427.00372.00368.00352.00368.00
Other Current Liabilities1,297.001,352.001,217.001,117.001,041.00963.00
Total Current Liabilities1,787.001,852.001,662.001,597.001,455.001,392.00
Long Term Debt3,633.003,845.003,918.004,029.003,962.004,148.00
Provision for Risks Charges0.000.000.00158.000.000.00
Deferred Tax Liabilities424.00410.00366.00382.00478.00496.00
Other Liabilities868.00866.00776.00645.00907.00931.00
Total Liabilities6,712.006,973.006,722.006,811.006,802.006,967.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity6,628.006,588.006,500.006,547.006,749.006,775.00
Total Shareholders Equity6,628.006,588.006,500.006,547.006,749.006,775.00
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity6,628.006,588.006,500.006,547.006,749.006,775.00
Total Liabilities & Stockholders Equity13,340.0013,561.0013,222.0013,358.0013,551.0013,742.00
Book Value Per Share13.2613.1913.0213.1713.5813.64
Tangible Book Value Per Share-2.40-2.92-2.90-3.30-3.24-3.40
Full-Time Employees---9,900--
Price to Book Ratio2.021.891.821.671.481.12
Return on Assets-1.09-1.46-1.85-1.790.273.16
Return on Equity-2.20-2.98-3.77-3.670.546.83
Return on Invested Capital0.180.520.55-2.61-0.320.10
Quick Ratio1.071.101.121.081.231.40
Current Ratio2.092.052.162.172.402.60

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income18.0054.0057.00-276.00-34.0011.00
Depreciation177.00171.00172.00174.00176.00169.00
Other Funds (Non Cash)52.0028.0047.00119.0018.005.00
Funds from Operations247.00253.00276.00-117.00160.00185.00
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-31.0024.00-263.00225.0059.0052.00
Cash from Operating Activities216.00277.0013.00108.00219.00237.00
Capital Expenditures-60.00-33.00-51.00-62.00-92.00-57.00
Net Assets From Acquisitions0.00-76.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses-2.00-1.00-9.00-2.00-9.001.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-62.00-110.00-60.00-64.00-101.00-56.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-215.00-73.00-16.00-1.00-188.00-446.00
Change in Long Term Debt-215.00-73.00-16.00-1.00-188.00-446.00
Issuance of Long Term Debt0.0050.000.002,106.000.000.00
Reduction of Long Term Debt-215.00-123.00-16.00-2,107.00-188.00-446.00
Net Financing Active Other Cash Flow-1.00-1.00-49.00-17.0035.00290.00
Other Financing Activities Uses-1.00-1.00-49.00-2.0020.000.00
Cash from Financing Activities-216.00-74.00-65.00-18.00-153.00-156.00
Exchange Rate Effect-3.009.00-5.0014.001.0027.00
Net Change in Cash-65.00102.00-117.0040.00-34.0052.00
Free Cash Flow156.00244.00-38.0046.00127.00180.00
Price to Free Cash Flow27.8032.8538.4439.5927.1919.78

Revenue breakdown

Aqua2024: 81.00M
Cattle2024: 1.01B 2025: 1.13B
Contract Manufacturing2024: 46.00M 2025: 53.00M
Pet Health2024: 2.14B 2025: 2.30B
Poultry2024: 796.00M 2025: 858.00M
Swine2024: 366.00M 2025: 379.00M
Non-US2024: 2.40B 2025: 2.48B
United States2024: 2.04B 2025: 2.23B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.66%32.9M494.5M6.14M
2026-10-156.29%31.1M494.5M6.19M
2026-09-307.54%37.3M494.6M6.11M
2026-09-156.43%31.8M494.6M5.96M
2026-08-316.25%30.9M494.6M6.03M
2026-08-146.01%29.7M494.6M6.49M
2026-07-317.28%36.0M494.6M5.89M
2026-07-157.24%35.8M494.4M5.77M
2026-06-307.12%35.2M494.4M5.77M
2026-06-157.20%35.6M494.1M6.19M
2026-05-296.71%33.2M494.3M5.88M
2026-05-156.44%31.9M495.1M5.55M
2026-04-304.92%24.3M494.9M4.93M
2026-04-154.96%24.6M494.8M5.03M
2026-03-315.18%25.5M492.6M5.10M
2026-03-133.48%17.1M492.6M4.77M
2026-02-273.06%15.1M492.6M5.09M
2026-02-133.74%18.4M492.6M5.00M
2026-01-304.72%23.2M492.3M5.43M
2026-01-154.70%23.1M492.3M5.37M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call15.0010.5012.008.073.1381.000.000.957-0.0510.004
call16.009.5011.000.002.8530.000.000.952-0.0500.004
call17.009.0010.000.002.5830.000.000.947-0.0490.004
call18.007.809.300.002.6850.000.000.941-0.0480.005
call19.007.008.007.662.0813.000.000.924-0.0540.006
call20.005.807.305.322.1571.000.000.905-0.0590.007
call21.004.706.105.101.71776.000.000.892-0.0560.008
call22.003.605.303.301.66026.000.000.876-0.0530.009
call23.003.103.903.051.08510.003.000.853-0.0490.010
call24.002.102.902.830.87236.000.000.818-0.0450.011
call25.001.301.901.800.6523414.000.743-0.0440.013
call26.000.701.200.930.59837.000.000.587-0.0520.016
call27.000.200.650.800.54784.000.000.418-0.0510.016
call28.000.050.400.050.58725.001.000.287-0.0480.014
call29.000.000.250.200.6276.000.000.185-0.0390.011
call30.000.000.350.050.7636.000.000.158-0.0430.010
call31.000.000.450.050.8892.000.000.141-0.0460.009
call32.000.000.450.001.0050.000.000.128-0.0490.009
call33.000.000.400.001.1140.000.000.118-0.0510.008
call34.000.000.400.001.2170.000.000.111-0.0530.008
call35.000.000.400.001.3140.000.000.104-0.0550.008
call36.000.000.400.001.4070.000.000.099-0.0560.007
call37.000.000.400.001.4960.000.000.094-0.0580.007
call38.000.000.400.001.5810.000.000.090-0.0590.007
call39.000.000.400.001.6620.000.000.087-0.0610.007
put15.000.000.400.002.3510.000.00-0.043-0.0500.004
put16.000.000.400.002.1240.000.00-0.048-0.0480.004
put17.000.000.400.181.9081.000.00-0.053-0.0470.004
put18.000.000.200.071.69915.000.00-0.059-0.0460.005
put19.000.000.250.151.5971280.00-0.076-0.0520.006
put20.000.000.450.131.4755230.00-0.095-0.0570.007
put21.000.000.450.151.27244.000.00-0.108-0.0540.008
put22.000.000.450.301.0792.000.00-0.125-0.0500.009
put23.000.000.350.090.8899460.00-0.148-0.0470.010
put24.000.050.300.600.7045870.00-0.182-0.0430.011
put25.000.150.350.780.5464.000.00-0.257-0.0410.013
put26.000.250.700.580.5355.000.00-0.417-0.0490.016
put27.000.751.301.750.5822.000.00-0.582-0.0480.016
put28.001.452.150.000.6970.000.00-0.713-0.0450.014
put29.002.003.100.000.8360.000.00-0.815-0.0360.011
put30.002.704.506.211.28520.000.00-0.842-0.0390.010
put31.003.705.500.001.4400.000.00-0.859-0.0430.009
put32.004.906.000.001.1730.000.00-0.872-0.0450.009
put33.005.907.500.001.7170.000.00-0.882-0.0470.008
put34.006.908.500.001.8430.000.00-0.889-0.0490.008
put35.007.709.400.001.8800.000.00-0.896-0.0510.008
put36.008.9010.500.002.0750.000.00-0.901-0.0520.007
put37.009.7011.300.002.0080.000.00-0.906-0.0540.007
put38.0010.9012.500.002.2850.000.00-0.910-0.0550.007
put39.0011.9013.500.002.3830.000.00-0.913-0.0560.007

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-068-KCurrent report2026-11-06SEC
2026-11-05SCHEDULE 13G/ASEC
2026-11-033Initial statement of beneficial ownership of securities2026-11-03SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-10-204Statement of changes in beneficial ownership of securities2026-10-16SEC
2026-10-204Statement of changes in beneficial ownership of securities2026-10-16SEC
2026-10-204Statement of changes in beneficial ownership of securities2026-10-16SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-15144Filing for proposed sale of securities under Rule 144.SEC
2026-10-064Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-064Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-064Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-224Statement of changes in beneficial ownership of securities2026-09-18SEC
2026-09-224Statement of changes in beneficial ownership of securities2026-09-18SEC
2026-09-224Statement of changes in beneficial ownership of securities2026-09-18SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-08-254Statement of changes in beneficial ownership of securities2026-08-21SEC
2026-08-254Statement of changes in beneficial ownership of securities2026-08-21SEC
2026-08-254Statement of changes in beneficial ownership of securities2026-08-21SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-18SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-07SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-07SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-1000100.05K1
2026-090000
2026-081.47M500
2026-070000
2026-060000
2026-05199.78K200
2026-040000
2026-030000
2026-020000
2026-010000
2025-12937.91K400
2025-110000

Institutional holders

Manager% owned
DODGE & COX13.49%
FMR LLC13.32%
BlackRock, Inc.9.78%
PRIMECAP MANAGEMENT CO/CA/9.10%
T. Rowe Price Investment Management, Inc.5.76%
DIMENSIONAL FUND ADVISORS LP5.02%
VANGUARD PORTFOLIO MANAGEMENT LLC4.54%
VANGUARD CAPITAL MANAGEMENT LLC4.53%
STATE STREET CORP3.22%
Winslow Capital Management, LLC2.71%

Funds

Fund% owned
Dodge & Cox Income Fund24.82%
Dodge & Cox Stock Fund8.63%
Dodge & Cox Global Bond Fund5.99%
Blackstone Private Multi-Asset Credit & Income Fund5.01%
VANGUARD PRIMECAP FUND3.55%
iShares Core S&P Mid-Cap ETF3.42%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.18%
iShares Broad USD High Yield Corporate Bond ETF2.92%
Dodge & Cox Balanced Fund2.60%
VANGUARD SMALL-CAP INDEX FUND2.29%

OakChart. ELAN. Cached 15 minutes.